Pharmaceutical formulation for delivery of receptor tyrosine kinase inhibiting (RTKI) compounds to the eye

Details for Australian Patent Application No. 2007356856 (hide)

Owner Alcon, Inc.

Inventors Zhang, Huixiang; Han, Wesley Wehsin; Jani, Rajni

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007356856

PCT Pub. Number WO2009/014510

Filing date 20 July 2007

Wipo publication date 29 January 2009

International Classifications

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

Event Publications

18 February 2010 PCT application entered the National Phase

  PCT publication WO2009/014510 Priority application(s): WO2009/014510

16 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007356874-Braided occlusion device having repeating expanded volume segments separated by articulation segments

2007356845-Inactivated staphylococcal whole-cell vaccine